Search results
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 3 days agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
BioNTech says 90% of 2024 revenues will accrue at end of year
WSAU Wausau· 3 days agoFRANKFURT (Reuters) - Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 4 hours agoHowever, management delayed filing an emergency use authorization (EUA) application in the U.S., and...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 3 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 3 days agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 3 days agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 3 days agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...
Moderna's New RSV Vaccine Undercuts the Promise of mRNA
Bloomberg via Yahoo Finance· 3 hours ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Why Earnings Season Could Be Great for BioNTech (BNTX)
Zacks· 6 days agoFree Report) may be one such company. In fact, the Most Accurate Estimate for the current quarter is currently pegged at an earnings of 14 cents per share for BNTX, compared to a broader Zacks ...
AstraZeneca pulls its COVID-19 vaccine from the European market
Stamford Advocate· 12 hours agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
